Cargando…
Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis
Background: Big data and real-world data (RWD) have been increasingly used to measure the effectiveness and costs in cost-effectiveness analysis (CEA). However, the characteristics and methodologies of CEA based on big data and RWD remain unknown. The objectives of this study were to review the char...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562301/ https://www.ncbi.nlm.nih.gov/pubmed/34737696 http://dx.doi.org/10.3389/fphar.2021.700012 |
_version_ | 1784593235683835904 |
---|---|
author | Lu, Z. Kevin Xiong, Xiaomo Lee, Taiying Wu, Jun Yuan, Jing Jiang, Bin |
author_facet | Lu, Z. Kevin Xiong, Xiaomo Lee, Taiying Wu, Jun Yuan, Jing Jiang, Bin |
author_sort | Lu, Z. Kevin |
collection | PubMed |
description | Background: Big data and real-world data (RWD) have been increasingly used to measure the effectiveness and costs in cost-effectiveness analysis (CEA). However, the characteristics and methodologies of CEA based on big data and RWD remain unknown. The objectives of this study were to review the characteristics and methodologies of the CEA studies based on big data and RWD and to compare the characteristics and methodologies between the CEA studies with or without decision-analytic models. Methods: The literature search was conducted in Medline (Pubmed), Embase, Web of Science, and Cochrane Library (as of June 2020). Full CEA studies with an incremental analysis that used big data and RWD for both effectiveness and costs written in English were included. There were no restrictions regarding publication date. Results: 70 studies on CEA using RWD (37 with decision-analytic models and 33 without) were included. The majority of the studies were published between 2011 and 2020, and the number of CEA based on RWD has been increasing over the years. Few CEA studies used big data. Pharmacological interventions were the most frequently studied intervention, and they were more frequently evaluated by the studies without decision-analytic models, while those with the model focused on treatment regimen. Compared to CEA studies using decision-analytic models, both effectiveness and costs of those using the model were more likely to be obtained from literature review. All the studies using decision-analytic models included sensitivity analyses, while four studies no using the model neither used sensitivity analysis nor controlled for confounders. Conclusion: The review shows that RWD has been increasingly applied in conducting the cost-effectiveness analysis. However, few CEA studies are based on big data. In future CEA studies using big data and RWD, it is encouraged to control confounders and to discount in long-term research when decision-analytic models are not used. |
format | Online Article Text |
id | pubmed-8562301 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85623012021-11-03 Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis Lu, Z. Kevin Xiong, Xiaomo Lee, Taiying Wu, Jun Yuan, Jing Jiang, Bin Front Pharmacol Pharmacology Background: Big data and real-world data (RWD) have been increasingly used to measure the effectiveness and costs in cost-effectiveness analysis (CEA). However, the characteristics and methodologies of CEA based on big data and RWD remain unknown. The objectives of this study were to review the characteristics and methodologies of the CEA studies based on big data and RWD and to compare the characteristics and methodologies between the CEA studies with or without decision-analytic models. Methods: The literature search was conducted in Medline (Pubmed), Embase, Web of Science, and Cochrane Library (as of June 2020). Full CEA studies with an incremental analysis that used big data and RWD for both effectiveness and costs written in English were included. There were no restrictions regarding publication date. Results: 70 studies on CEA using RWD (37 with decision-analytic models and 33 without) were included. The majority of the studies were published between 2011 and 2020, and the number of CEA based on RWD has been increasing over the years. Few CEA studies used big data. Pharmacological interventions were the most frequently studied intervention, and they were more frequently evaluated by the studies without decision-analytic models, while those with the model focused on treatment regimen. Compared to CEA studies using decision-analytic models, both effectiveness and costs of those using the model were more likely to be obtained from literature review. All the studies using decision-analytic models included sensitivity analyses, while four studies no using the model neither used sensitivity analysis nor controlled for confounders. Conclusion: The review shows that RWD has been increasingly applied in conducting the cost-effectiveness analysis. However, few CEA studies are based on big data. In future CEA studies using big data and RWD, it is encouraged to control confounders and to discount in long-term research when decision-analytic models are not used. Frontiers Media S.A. 2021-10-19 /pmc/articles/PMC8562301/ /pubmed/34737696 http://dx.doi.org/10.3389/fphar.2021.700012 Text en Copyright © 2021 Lu, Xiong, Lee, Wu, Yuan and Jiang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Lu, Z. Kevin Xiong, Xiaomo Lee, Taiying Wu, Jun Yuan, Jing Jiang, Bin Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis |
title | Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis |
title_full | Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis |
title_fullStr | Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis |
title_full_unstemmed | Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis |
title_short | Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis |
title_sort | big data and real-world data based cost-effectiveness studies and decision-making models: a systematic review and analysis |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562301/ https://www.ncbi.nlm.nih.gov/pubmed/34737696 http://dx.doi.org/10.3389/fphar.2021.700012 |
work_keys_str_mv | AT luzkevin bigdataandrealworlddatabasedcosteffectivenessstudiesanddecisionmakingmodelsasystematicreviewandanalysis AT xiongxiaomo bigdataandrealworlddatabasedcosteffectivenessstudiesanddecisionmakingmodelsasystematicreviewandanalysis AT leetaiying bigdataandrealworlddatabasedcosteffectivenessstudiesanddecisionmakingmodelsasystematicreviewandanalysis AT wujun bigdataandrealworlddatabasedcosteffectivenessstudiesanddecisionmakingmodelsasystematicreviewandanalysis AT yuanjing bigdataandrealworlddatabasedcosteffectivenessstudiesanddecisionmakingmodelsasystematicreviewandanalysis AT jiangbin bigdataandrealworlddatabasedcosteffectivenessstudiesanddecisionmakingmodelsasystematicreviewandanalysis |